| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.5 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.5 |